David Botstein, a towering figure in American biology and genetics whose groundbreaking work laid foundational principles for understanding the human genome and disease, passed away on February 27, 2026, at the age of 83 in Half Moon Bay, California. Born on September 8, 1942, in Zurich, Switzerland, Dr. Botstein's intellectual curiosity and rigorous approach to science profoundly shaped modern genomics and inspired generations of researchers.

Dr. Botstein's academic journey began at Harvard University, where he earned his A.B. in 1963, followed by a Ph.D. from the University of Michigan in 1967. His early career saw him join the faculty of the Massachusetts Institute of Technology, where he rose to the esteemed position of Professor of Genetics. It was during this period that he began to establish himself as a visionary in the field, contributing significantly to bacterial genetics and the understanding of transposable elements.

A pivotal moment in his career, and indeed in the history of genetics, came in 1980 when Dr. Botstein, along with his collaborators, proposed a revolutionary method for constructing a genetic linkage map of the human genome using restriction fragment length polymorphisms (RFLPs). This theoretical contribution provided the essential roadmap that would later become one of the cornerstones of the ambitious Human Genome Project, enabling the mapping of genes responsible for numerous human diseases, including Huntington's disease and BRCA1.

His influence extended beyond academia into the burgeoning biotechnology industry. In 1987, Dr. Botstein joined Genentech, Inc. as Vice President—Science, bringing his profound scientific insight to a commercial setting. He later returned to academia in 1990, becoming the Chairman of the Department of Genetics at Stanford University, where he continued to drive innovation in genetic research and education.

Throughout the 1990s, Dr. Botstein's research pivoted to the emerging science of genomics. He was instrumental in co-founding the Saccharomyces Genome Database with J. Michael Cherry, a vital international resource connecting genomic sequences with biological functions, and contributed to the establishment of the Gene Ontology Consortium. Collaborating with Patrick O. Brown, he also played a key role in developing DNA microarray technology and analytical methods, which were adapted to classify and study human tumors, leading to the discovery of distinct tumor subtypes.

In 2003, Dr. Botstein took on the directorship of the Lewis-Sigler Institute for Integrative Genomics at Princeton University, a role he held until 2013. Under his leadership, the institute fostered an innovative Integrated Science Curriculum, which combined biology, physics, chemistry, and computer science to train the next generation of interdisciplinary scientists. His commitment to education and mentorship was a hallmark of his career, with many of his students and postdocs achieving significant success in the field.

Dr. Botstein's exceptional contributions were recognized with numerous prestigious awards, including the Eli Lilly Award in Microbiology (1978), the Genetics Society of America Medal (1988), the Allan Award of the American Society of Human Genetics (1989), and the Gruber Prize in Genetics (2003). He was also honored with the Albany Medical Center Prize (2010), the Dan David Prize (2012), and the Breakthrough Prize in Life Sciences (2013) for his seminal work in genetic mapping. In 2020, he received the Thomas Hunt Morgan Medal from the Genetics Society of America.

From 2013 to 2023, Dr. Botstein served as the founding Chief Scientific Officer of Calico, a biotechnology company established by Google with a focus on the biology of aging, aiming to devise interventions for longer, healthier lives. His election to the U.S. National Academy of Sciences in 1981 and the Institute of Medicine in 1993 underscored his profound impact and leadership in the scientific community. David Botstein's legacy is one of transformative scientific discovery, dedicated mentorship, and an unwavering pursuit of knowledge that reshaped our understanding of life itself.